News

Explore the profound impact of mentorship in medicine, highlighting personal journeys and the legacy of influential mentors like Wassfy Hanna, MD.

Emergency departments face challenges in detecting suicidality among patients with trauma, highlighting the need for effective screening and intervention strategies.

Researchers unveil a groundbreaking nasal spray using lithium-loaded gold nanoparticles, targeting brain diseases with reduced adverse effects.

Explore the vital role of psycho-oncology in supporting cancer patients' mental health during diagnosis and treatment challenges.

AI chatbots raise critical concerns in mental health, revealing risks of suicide ideation, maladaptive thinking, and the need for clinician awareness and intervention.

AI chatbots pose significant risks in mental health, often exacerbating issues like self-harm and delusions, highlighting urgent regulatory needs.

This infographic can help you review 6 highlights from the INTEGRATE Guidelines.

Explore the timeless myths and tales that shape our understanding of AI and chatbots, revealing humanity's complex relationship with artificial life.

Exploring the psychological impact of global crises, this article highlights the urgent need for mental health interventions amid escalating trauma and grief.

Mental health professionals cultivate resilience through emotional intelligence, trauma-informed care, and supportive organizational practices, enhancing well-being and care outcomes.

Explore the evolving landscape of psychiatric diagnosis and treatment, highlighting the gap between evidence-based standards and real-world practices.

International guidelines for schizophrenia treatment standardize care, addressing disparities and emphasizing proactive metabolic management for better patient outcomes.

Explore the intersection of music, psychiatry, and hope as Beethoven's 9th Symphony inspires joy amidst despair and conflict in today's world.

Alto Neuroscience's ALTO-101 gains FDA fast track designation, promising a novel treatment for cognitive impairment in schizophrenia.

Review the September Special Report with articles on geriatric psychiatry, from a variety of experts.

H. Steven Moffic, MD, explores the ongoing challenges for women in the military and society, highlighting the need for recognition of their unique contributions.

A new study reveals the ReCODE program significantly reduces depression in patients with cognitive impairment, enhancing both mood and cognitive health.

Reproductive psychiatrist Sarah Oreck, MD, MS challenges the FDA's claims linking acetaminophen use in pregnancy to autism and ADHD, advocating for informed maternal care.

Explore powerful memoirs that delve into addiction, recovery, and the emotional struggles faced by individuals and families in the journey to healing.

The Ububele Educational and Psychotherapy Trust enhances mental health access in South Africa, focusing on early childhood support and community-based interventions to break cycles of emotional poverty.

Bristol Myers Squibb's BMS-986446 receives FDA Fast Track Designation, aiming to transform early Alzheimer disease treatment by targeting tau pathology.

Socrates’ suicide as an affirmative choice.

Late-life depression poses unique challenges, impacting cognitive function and requiring tailored treatment strategies for older adults.

Explore how lifestyle choices like diet, exercise, and sleep enhance mental health outcomes in psychiatry. Share your insights and experiences today with our October theme!

Recent research links nighttime screen use and easy medication access to increased suicide attempts among adolescents, highlighting urgent mental health concerns.

Lipocine Inc. advances LPCN 1154, an oral treatment for postpartum depression, aiming for rapid relief and improved patient access by 2026.

Explore the dramatic evolution of AI, from early concepts to modern chatbots, and the uncertain future they create for humanity.

What disease states are most prominently featured in recent research? Learn more in this exclusive article.

Exploring the intersection of free speech and psychiatry, this article examines societal risks and the ethical responsibilities of mental health professionals.

New phase 3 data highlights seltorexant's potential as a safer adjunctive treatment for major depressive disorder with insomnia, despite not meeting primary end points. Andrew J. Cutler, MD, shares his thoughts.